References
- Hammond P. B., Beliles R. P. Metals, in Casarett and Doull's Toxicology, Second Ed., J. Doull, CD. Klaasen, M.O. Amdur. Macmillan Publishing Co., New York 1980; 439–440
- Salmon R. P., Brown P., Williams R., Read A. G. Evaluation of colloidal bismuth (De Nol) in the treatment of duodenal ulcer employing endoscopic selection and follow up. Gut 1972; 15: 189–194
- Vantrappen G., Rutgeerts P., Broeckaert L., Janssens J. Randomized open controlled trial of colloidal bismuth subcitrate tablets and cimetidine in the treatment of duodenal ulcer. Gut 1980; 21: 329–333
- Buge A., Supino-Viterbo V., Rancurel G., Pontes C. Epileptic phenomena in bismuth toxic encephalopathy. J. Neurology Neurosurgery Psychiatry 1981; 44: 62–67
- Monseau G., Struelens M., Roland M. Bismuth encephalopathy. Acta Neurol. Belq. 1976; 76: 301–308
- Lee S. P., Lim T. H., Pybus J., Clarke A. C. Tissue distribution of orally administered bismuth in the rat. Clinical and Experimental Pharmacology and Physiology 1980; 7: 319–324
- Basinger M. A., Jones M. M. Structural requirements for chelate antidotal efficacy in acute antimony(III) intoxication. Res. Commun. Chem. Path. Pharmacol. 1981; 32: 355–363
- Burns R., Thomas D. W., Barron V. J. Reversible encephalopathy possibly associated with bismuth subgallate ingestion. Brit. Med. J. 1974; 1: 220–223
- Goule J. P., Husson A., Fondimare A., Rapoport F., Lebreton M., Lajarige V. Encephalopathie aux sels insolubles de bismuth. Nouv. Presse Med. 1975; 4: 1366
- Basinger M. A., Johnson J. E., Burka L. T., Jones M. M. Antidotes for acute beryllium sulfate intoxication in mice. Res. Comm. Chem. Path. Pharmacol. 1982; 36(3)519–522
- WHO. Drug Information Circular April, 1981; 28, No. 196